Abstract
The association of combined oral contraceptives (OC) with higher blood pressure (BP) may be attenuated with pills with smaller doses of oestrogen. The effect of stopping OC on BP of patients with hypertension was not described to date. In a cohort study of patients with hypertension, we identified 72 women using OC among 2112 patients seen from 1989 to 2002. Stopping hormonal contraception was recommended to all. The main outcome measurement was BP change in women who stopped (n=44) and who did not stop (n=28) OC, adjusting for baseline BP and age. Odds ratio for having a reduction of at least 20 mmHg in systolic blood pressure (SBP) or 10 mmHg in diastolic blood pressure (DBP), adjusting for age, change in weight and prescription of BP-lowering drugs, were calculated. The mean follow-up time was 6.6±7.5 months. Participants who stopped and did not stop OC had similar baseline characteristics. The deltas of SBP (adjusted) were 15.1±2.6 mmHg in patients who stopped and 2.8±3.2 mmHg in patients who did not stop OC (P=0.004). The corresponding values for DBP were 10.4±1.8 and 2.7±2.2 mmHg (P=0.008), respectively. The odds ratio (adjusted) for having a decrease of at least 20 mmHg in SBP or 10 mmHg in DBP was 0.28 (95% CI 0.08–0.90) in patients who stopped OC. Stopping OC is an effective antihypertensive intervention in a clinical setting.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Factors associated with prognostic or treatment outcomes in HIV/AIDS patients with and without hypertension in Eswatini
Scientific Reports Open Access 21 June 2021
-
Hypertension and Reproduction
Current Hypertension Reports Open Access 13 March 2020
-
Österreichischer Blutdruckkonsens 2019
Wiener klinische Wochenschrift Open Access 01 November 2019
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout

References
Peterson LS . Contraceptive use in the United States: 1982–90. Advance Data, No. 260, February 14, 1995. Division of Vital Health Statistics, National Center for Health Statistics, Centers for Disease Control and Prevention. 1995; 260: 1–15.
Moreno L . Residential mobility and contraceptive use in northeastern Brazil. DHS Working Papers No. 9. Macro International Inc., Calverton, MD, 1994, pp 1–36.
Fuchs FD et al. Prevalence of systemic arterial hypertension and associated risk factors in the Porto Alegre metropolitan area. Arq Bras Cardiol 1994; 63: 473–479.
Nichols M et al. Effect of four combined oral contraceptives on blood pressure in the pill-free interval. Contraception 1993; 47: 367–376.
Shen Q et al. Blood pressure changes and hormonal contraceptives. Contraception 1994; 50: 131–141.
MacKay HT . Gynecology. In: Tierney LM, McPhee SJ, Papadakis MA (eds) Current Medical Diagnosis & Treatment, 43th edn. McGraw-Hill: New York, 2004, pp 694–728.
Malatino LS, Glen L, Wilson ES . The effects of low dose estrogen–progestogen oral contraceptives on blood pressure and the renin–angiotensin system. Curr Ther Res 1988; 43: 743–749.
Kaplan NM . The treatment of hypertension in women. Arch Intern Med 1995; 155: 563–567.
Wilson ESB, Cruickshank J, McMaster M, Weir RJ . A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestagen. Br J Obstet Gynaecol 1984; 91: 1254–1260.
ChasanTaber L et al. Prospective study of oral contraceptives and hypertension among women in the United States. Circulation 1996; 94: 483–489.
Lubianca JN, Faccin CS, Fuchs FD . Oral contraceptives: a risk factor for uncontrolled blood pressure among hypertensive women. Contraception 2003; 67: 19–24.
Fuchs FD et al. Study of the usefulness of optic fundi examination of patients with hypertension in a clinical setting. J Hum Hypertens 1995; 9: 547–551.
Fuchs FD et al. Blood pressure effects of antihypertensive drugs and changes in lifestyle in a Brazilian hypertensive cohort. J Hypertens 1997; 15: 783–792.
Lubianca Neto JF et al. Is epistaxis evidence of end-organ damage in patients with hypertension? Laryngoscope 1999; 109: 1111–1115.
Fuchs FD et al. Headache is not more frequent among patients with moderate to severe hypertension. J Hum Hypertens 2003; 17: 787–790.
Chobanian AV et al. The Seventh Report of Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. The JNC 7 Report. JAMA 2003; 289: 2560–2572.
Weir RJ et al. Blood pressure in women taking oral contraceptives. BMJ 1974; 1: 533–535.
Cook NR et al. Regression analysis of changes in blood pressure with oral contraceptive use. Am J Epidemiol 1985; 121: 530–540.
Curtis KM, Chrisman CE, Peterson HB . WHO programme for mapping Best Practices in Reproductive Health. Contraception for women in selected circumstances. Obstet Gynecol 2002; 99: 1100–1112.
Narkiewicz K et al. Ambulatory blood pressure in mild hypertensive women taking oral contraceptives—a case–control study. Am J Hypertens 1995; 8: 249–253.
Pooling Project Cooperative Group. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the National Cooperative Pooling Project. J Chron Dis 1978; 31: 201–306.
MacMahon S et al. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765–774.
Lewington S et al. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903–1913.
Acknowledgements
This work was supported by the grants CAPES, CNPq, and FAPERGS, Brazil.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lubianca, J., Moreira, L., Gus, M. et al. Stopping oral contraceptives: an effective blood pressure-lowering intervention in women with hypertension. J Hum Hypertens 19, 451–455 (2005). https://doi.org/10.1038/sj.jhh.1001841
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1001841
Keywords
- oral contraceptives
- blood pressure
This article is cited by
-
Hypertension in Women: Impact of Contraception, Fertility, and Hormone Treatment
Current Cardiovascular Risk Reports (2022)
-
Factors associated with prognostic or treatment outcomes in HIV/AIDS patients with and without hypertension in Eswatini
Scientific Reports (2021)
-
Combined Oral Contraceptive Pill-Induced Hypertension and Hypertensive Disorders of Pregnancy: Shared Mechanisms and Clinical Similarities
Current Hypertension Reports (2021)
-
Hypertension in Women Across the Lifespan
Current Atherosclerosis Reports (2021)
-
Hypertension and Reproduction
Current Hypertension Reports (2020)